260 related articles for article (PubMed ID: 36325577)
61. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
62. The Translational Regulation in mTOR Pathway.
Yang M; Lu Y; Piao W; Jin H
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740927
[TBL] [Abstract][Full Text] [Related]
63. eIF4E activity is regulated at multiple levels.
Raught B; Gingras AC
Int J Biochem Cell Biol; 1999 Jan; 31(1):43-57. PubMed ID: 10216943
[TBL] [Abstract][Full Text] [Related]
64. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
[TBL] [Abstract][Full Text] [Related]
65. KRAS-related proteins in pancreatic cancer.
Mann KM; Ying H; Juan J; Jenkins NA; Copeland NG
Pharmacol Ther; 2016 Dec; 168():29-42. PubMed ID: 27595930
[TBL] [Abstract][Full Text] [Related]
66. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
Alonso N; Diaz Nebreda A; Monczor F; Gutkind JS; Davio C; Fernandez N; Shayo C
Biochim Biophys Acta; 2016 Sep; 1860(9):1998-2007. PubMed ID: 27316323
[TBL] [Abstract][Full Text] [Related]
67. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
Choi C; Kwon J; Lim S; Helfman DM
Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
[TBL] [Abstract][Full Text] [Related]
68. Regulation of mRNA Translation in Neurons-A Matter of Life and Death.
Kapur M; Monaghan CE; Ackerman SL
Neuron; 2017 Nov; 96(3):616-637. PubMed ID: 29096076
[TBL] [Abstract][Full Text] [Related]
69. The oncogene eIF4E: using biochemical insights to target cancer.
Carroll M; Borden KL
J Interferon Cytokine Res; 2013 May; 33(5):227-38. PubMed ID: 23472659
[TBL] [Abstract][Full Text] [Related]
70. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
71. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway.
Tsokas P; Ma T; Iyengar R; Landau EM; Blitzer RD
J Neurosci; 2007 May; 27(22):5885-94. PubMed ID: 17537959
[TBL] [Abstract][Full Text] [Related]
72. News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer's Disease, RNA-Based Vaccines and mRNA Therapeutics.
Volloch V; Rits-Volloch S
Ann Integr Mol Med; 2021; 2():131-173. PubMed ID: 33942036
[TBL] [Abstract][Full Text] [Related]
73. A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway.
Zhao L; Li C; Liu F; Zhao Y; Liu J; Hua Y; Liu J; Huang J; Ge C
Onco Targets Ther; 2017; 10():2115-2126. PubMed ID: 28442920
[TBL] [Abstract][Full Text] [Related]
74. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
[TBL] [Abstract][Full Text] [Related]
75. Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer.
Mortazavi M; Moosavi F; Martini M; Giovannetti E; Firuzi O
Crit Rev Oncol Hematol; 2022 Aug; 176():103749. PubMed ID: 35728737
[TBL] [Abstract][Full Text] [Related]
76. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells.
Fitzgerald TL; Lertpiriyapong K; Cocco L; Martelli AM; Libra M; Candido S; Montalto G; Cervello M; Steelman L; Abrams SL; McCubrey JA
Adv Biol Regul; 2015 Sep; 59():65-81. PubMed ID: 26257206
[TBL] [Abstract][Full Text] [Related]
77. OLA1 regulates protein synthesis and integrated stress response by inhibiting eIF2 ternary complex formation.
Chen H; Song R; Wang G; Ding Z; Yang C; Zhang J; Zeng Z; Rubio V; Wang L; Zu N; Weiskoff AM; Minze LJ; Jeyabal PV; Mansour OC; Bai L; Merrick WC; Zheng S; Shi ZZ
Sci Rep; 2015 Aug; 5():13241. PubMed ID: 26283179
[TBL] [Abstract][Full Text] [Related]
78. Oncogenic AKTivation of translation as a therapeutic target.
Hsieh AC; Truitt ML; Ruggero D
Br J Cancer; 2011 Jul; 105(3):329-36. PubMed ID: 21772331
[TBL] [Abstract][Full Text] [Related]
79. The coupling of translational control and stress responses.
Houston R; Sekine S; Sekine Y
J Biochem; 2020 Aug; 168(2):93-102. PubMed ID: 32484875
[TBL] [Abstract][Full Text] [Related]
80. Regulation of translation initiation factor eIF2B at the hub of the integrated stress response.
Pavitt GD
Wiley Interdiscip Rev RNA; 2018 Nov; 9(6):e1491. PubMed ID: 29989343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
